We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$408B
AUM Growth
+$23B
Cap. Flow
+$1.72B
Cap. Flow %
0.42%
Top 10 Hldgs %
28.09%
Holding
14,143
New
3,275
Increased
5,446
Reduced
4,187
Closed
1,034

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$627M
2
BIDU icon
Baidu
BIDU
+$542M
3
MBB icon
iShares MBS ETF
MBB
+$492M
4
NVDA icon
NVIDIA
NVDA
+$429M
5
CMCSA icon
Comcast
CMCSA
+$421M

Sector Composition

Rank Sector Weight
1 Technology 3.73%
2 Healthcare 3.22%
3 Consumer Discretionary 2.4%
4 Financials 2.32%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNLX
11526
PUT
DELISTED
Renalytix plc American Depositary Shares
RNLX
$203K ﹤0.01%
+7,900
New +$198K
VBIV
11527
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$203K ﹤0.01%
2,167
-3,280
-60% -$333K
CBD
11528
DELISTED
Companhia Brasileira de Distribuicao
CBD
$203K ﹤0.01%
+34,941
New +$423K
FGH
11529
DELISTED
FG Group Holdings Inc.
FGH
$203K ﹤0.01%
+77,950
New +$193K
BLCM
11530
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$203K ﹤0.01%
54,047
+27,077
+100% +$118K
KRBP
11531
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$203K ﹤0.01%
724
+336
+87% +$98.5K
ESSC
11532
PUT
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$203K ﹤0.01%
+20,300
New +$204K
JRO
11533
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$203K ﹤0.01%
+21,286
New +$197K
ALGM icon
11534
Allegro MicroSystems
ALGM
$7.91B
$202K ﹤0.01%
+7,986
New +$228K
APYX icon
11535
Apyx Medical
APYX
$175M
$202K ﹤0.01%
+20,833
New +$208K
EAOM icon
11536
iShares ESG Aware Moderate Allocation ETF
EAOM
$9.38M
$202K ﹤0.01%
+7,248
New +$202K
GROW icon
11537
PUT
US Global Investors
GROW
$38.5M
$202K ﹤0.01%
29,000
+17,200
+146% +$114K
MOO icon
11538
PUT
VanEck Agribusiness ETF
MOO
$974M
$202K ﹤0.01%
+2,300
New +$195K
VWOB icon
11539
CALL
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
$202K ﹤0.01%
+2,600
New +$207K
PYR
11540
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$202K ﹤0.01%
+29,850
New +$220K
SCR
11541
CALL
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
$202K ﹤0.01%
+7,500
New +$196K
CLPT icon
11542
CALL
ClearPoint Neuro
CLPT
$408M
$201K ﹤0.01%
+9,500
New +$203K
CLVT icon
11543
PUT
Clarivate
CLVT
$1.18B
$201K ﹤0.01%
+7,600
New +$208K
CPRX
11544
DELISTED
Catalyst Pharmaceutical
CPRX
$201K ﹤0.01%
43,537
-139,000
-76% -$552K
DTIL icon
11545
CALL
Precision BioSciences
DTIL
$191M
$201K ﹤0.01%
647
-113
-15% -$39.6K
DUG icon
11546
CALL
ProShares UltraShort Energy
DUG
$21.5M
$201K ﹤0.01%
+650
New +$248K
QAT icon
11547
iShares MSCI Qatar ETF
QAT
$63.8M
$201K ﹤0.01%
+10,688
New +$198K
UDEC
11548
Innovator US Equity Ultra Buffer ETF December
UDEC
$249M
$201K ﹤0.01%
+6,924
New +$198K
UXIN
11549
PUT
Uxin Ltd
UXIN
$222M
$201K ﹤0.01%
1,719
+757
+79% +$90.4K
XBIO icon
11550
Xenetic Biosciences
XBIO
$6.53M
$201K ﹤0.01%
+9,200
New +$242K

Similar funds

Citadel Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Citadel Advisors held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q1 2021 filing shows 3,275 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
  • Citadel Advisors added most to Amazon in Q1 2021, an estimated $627M increase.
  • Citadel Advisors's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
  • Citadel Advisors fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
  • Citadel Advisors's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
  • Citadel Advisors opened 3,275 new positions and closed 1,034 in Q1 2021.
  • Citadel Advisors's portfolio value rose 6% quarter-over-quarter to $408B.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.